Alfasigma S.p.a.

This study follows 155 adults in France with moderate to severe rheumatoid arthritis who are starting filgotinib. Researchers will track how long people stay on the drug, how well it controls disease activity, and any side effects over two years. The goal is to see how the medici…

This study follows about 500 adults with moderate to severe ulcerative colitis who are starting filgotinib, a medication that helps control the disease. Researchers want to see how long people stay on the drug, how well it works, and how it affects quality of life in everyday med…

This study tests a daily pill called filgotinib in about 495 adults with active axial spondyloarthritis, a type of arthritis that causes back pain and stiffness. Participants receive either 200 mg, 100 mg, or a placebo to see if the drug reduces symptoms and inflammation. The goa…

This study follows over 1,300 adults with moderate to severe rheumatoid arthritis who are prescribed filgotinib as part of their normal care. Researchers will track how long patients stay on the drug, and how it affects their pain, fatigue, and daily life over two years. The goal…